Rimsys Launches Community-Driven Regulatory Intelligence
May 06 2024 - 3:00AM
Business Wire
Now in beta, Rimsys Intel will leverage the strong expertise of
RAPS RAC holders as part of an innovative, community-driven
approach to regulatory intelligence.
Rimsys, a leading regulatory information management software for
the medtech industry, announced today the beta launch of its
community-driven, centralized hub for global regulatory
intelligence data, Rimsys Intel. Rimsys Intel builds upon Rimsys’
mission of increasing the availability of life-changing medical
technologies by giving users free access to regulatory
intelligence, including regulatory affiliations, legislation, UDI
requirements, risk class information for medical devices and IVDs,
in addition to market access requirements for each regulated
country.
“As part of our core company value to empower each other, Rimsys
believes that regulatory intelligence should be easily accessible
and free. I’m thrilled to provide a solution that enables medtech
teams to make more informed decisions about market access for their
products and execute faster,” said James Gianoutsos, Founder &
CEO of Rimsys.
To help keep Rimsys Intel up to date amid evolving global
regulations, Rimsys is engaging RAPS Regulatory Affairs Certificate
(RAC) holders. RAPS, the largest organization of regulatory affairs
professionals in the life sciences industry, offers this credential
to regulatory affairs professionals who demonstrate proficiency in
the scope and application of medical device and pharmaceutical
regulations. RAC holders who sign up for and review Rimsys Intel
data will have the opportunity to earn recertification credits that
count toward maintaining their RAC status.
“As Rimsys participates in RAPS Euro Convergence this week, I’m
proud to be among its community of inspiring, helpful, and
knowledgeable innovators,” said James. “Our collaboration with RAC
holders is a very exciting and mutually beneficial one. Not only is
the medtech community able to leverage regulatory intelligence
verified by highly regarded RAC holders, but we’re also giving RAC
holders a free way to earn recertification credits and further
their professional development.”
From solopreneurs to enterprise-level medtech companies, Rimsys
Intel is equalizing access to global regulatory intelligence data
by making it free for the community. Rimsys Intel is currently open
to a limited number of beta users. Those interested in signing up
for Rimsys Intel can join the beta waitlist here. Rimsys Intel will
become generally available later this year.
About Rimsys
Rimsys is improving global health by accelerating delivery and
increasing availability of life-changing medical technologies.
Rimsys Regulatory Information Management (RIM) software digitizes
and automates regulatory activities, helping medtech regulatory
affairs teams to plan more effectively, execute more quickly, and
confidently ensure global regulatory compliance. Rimsys is designed
around medtech workflows and supports a full breadth of regulatory
activities including registrations, submissions, UDI, essential
principles, and standards management in a single, integrated
platform. For more information, visit www.rimsys.io.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240506163680/en/
Kelly Riedel Rimsys kelly@rimsys.io